Dopamine Blocks Stress-Mediated Ovarian Carcinoma Growth
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Purpose: Increased adrenergic activity in response to chronic stress is known to promote tumor growth by stimulating the tumor microenvironment. The focus of the current study was to determine whether dopamine, an inhibitory catecholamine, could block the effects of chronic stress on tumor growth. Experimental Design: Expression of dopamine receptors (DR1–DR5) was analyzed by reverse transcriptase-PCR and by Western blotting. In vitro effects of dopamine on cell viability, apoptosis, and migration were examined. For in vivo therapy, murine and human DR2-siRNAs were incorporated into chitosan nanoparticles (CH-NP). Results: In this model of chronic stress, tumoral norepinephrine levels remained elevated whereas dopamine levels were significantly decreased compared with nonstressed animals. Daily restraint stress resulted in significantly increased tumor growth in both immunodeficient (SKOV3ip1 and HeyA8) and immunocompetent (ID8) ovarian cancer models. This increase was completely blocked with daily dopamine treatment. Dopamine treatment also blocked the stress-induced increase in angiogenesis. Endothelial and ovarian cancer cells expressed all dopamine receptors except for the lack of DR3 expression in ovarian cancer cells. DR2 was responsible for the inhibitory effects of dopamine on tumor growth and microvessel density as well as the stimulatory effect on apoptosis, as the DR2 antagonist eticlopride reversed these effects. Dopamine significantly inhibited cell viability and stimulated apoptosis in vitro. Moreover, dopamine reduced cyclic AMP levels and inhibited norepinephrine and vascular permeability factor/VEGF-induced Src kinase activation. Conclusions: Dopamine depletion under chronic stress conditions creates a permissive microenvironment for tumor growth that can be reversed by dopamine replacement. Clin Cancer Res; 17(11); 3649–59. ©2011 AACR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dopamine receptors: from structure to function
MISSALE, C., NASH, S. R., ROBINSON, S. W., JABER, M., & CARON, M. G. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.1.189 · Cited by 3,633
Stress-induced immune dysfunction: implications for health
Glaser, R., & Kiecolt-Glaser, J. K. (2005) · Nature Reviews Immunology · doi:10.1038/nri1571 · Cited by 2,190
Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma
Thaker, P. H., Han, L. Y., Kamat, A. A., Arevalo, J. M., Takahashi, R., Lu, C., Jennings, N. B., Armaiz-Pena, G., Bankson, J. A., Ravoori, M., et al. (2006) · Nature Medicine · doi:10.1038/nm1447 · Cited by 1,320 · cited 4×
“Dopamine dose–response in vivo We have previously shown that chronic stress establishes favorable conditions for promoting angiogenesis in the tumor microenvironment by SNS activation (6).”
InfluentialSelf-citationThe influence of bio-behavioural factors on tumour biology: pathways and mechanisms
Antoni, M. H., Lutgendorf, S. K., Cole, S. W., Dhabhar, F. S., Sephton, S. E., McDonald, P. G., Stefanek, M., & Sood, A. K. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1820 · Cited by 981
Self-citationImperato, A., Angelucci, L., Casolini, P., Zocchi, A., & Puglisi-Allegra, S. (1992) · Brain Research · doi:10.1016/0006-8993(92)90274-d · Cited by 256 · cited 1×
“In contrast, under chronic stress conditions, dopamine levels are lower as a consequence of decreased release of dopamine (15).”
Depression, social support, and beta-adrenergic transcription control in human ovarian cancer
Lutgendorf, S. K., DeGeest, K., Sung, C. Y., Arevalo, J. M., Penedo, F., Lucci, J., Goodheart, M., Lubaroff, D., Farley, D. M., Sood, A. K., et al. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2008.04.155 · Cited by 215 · cited 1×
“Norepinephrine and epinephrine levels are known to be elevated in the plasma and tumor microenvironment of individuals with acute and chronic stress (4, 5).”
Self-citationThe incidence of cancer in schizophrenic patients.
Mortensen, P. B. (1989) · Journal of Epidemiology and Community Health · doi:10.1136/jech.43.1.43 · Cited by 175
Schizophrenia and cancer: an epidemiological study
Goldacre, M. J., Kurina, L. M., Wotton, C. J., Yeates, D., & Seagroatt, V. (2005) · British Journal of Psychiatry · doi:10.1192/bjp.187.4.334 · Cited by 123
Cited by
Dopamine receptors –IUPHAR R eview 13
Beaulieu, J., Espinoza, S., & Gainetdinov, R. R. (2015) · British Journal of Pharmacology · doi:10.1111/bph.12906 · Cited by 521
Chronic Stress Promotes Cancer Development
Dai, S., Mo, Y., Wang, Y., Xiang, B., Liao, Q., Zhou, M., Li, X., Li, Y., Xiong, W., Li, G., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01492 · Cited by 405
“In addition to increasing exercise (70) and psychological intervention (71–74) to regulate the patients’ stress, we can also use drugs that limit the transmission of the HPA axis and the downstream signaling pathways of the SNS, such as the β-adrenergic receptor antagonists [(9); Figure 2], COX2 inhibitors (COX2i) [(5…”
Nerve Dependence: From Regeneration to Cancer
Boilly, B., Faulkner, S., Jobling, P., & Hondermarck, H. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.02.005 · Cited by 290
Nerve–Cancer Cell Cross-talk: A Novel Promoter of Tumor Progression
Jobling, P., Pundavela, J., Oliveira, S. M. R., Roselli, S., Walker, M. M., & Hondermarck, H. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3180 · Cited by 272
“In addition, the effect of beta-blockers may also be related to the inhibition of stress, as dopamine, a stress inhibitory catecholamine has been shown to decrease ovarian cancer growth though an antiangiogenic effect (32, 33).”
BackgroundNeural Regulation of Hematopoiesis, Inflammation, and Cancer
Hanoun, M., Maryanovich, M., Arnal-Estapé, A., & Frenette, P. S. (2015) · Neuron · doi:10.1016/j.neuron.2015.01.026 · Cited by 265
Metadata
- Authors
- Moreno-Smith, M., Lu, C., Shahzad, M. M. K., Pena, G. N. A., Allen, J. K., Stone, R. L., Mangala, L. S., Han, H. D., Kim, H. S., Farley, D., Berestein, G. L., Cole, S. W., Lutgendorf, S. K., & Sood, A. K.
- Venue
- Clinical Cancer Research
- Published
- 2011-06-01
- Volume
- 17
- Issue
- 11
- Pages
- 3649-3659
- ISSN
- 1078-0432 (ISSN-L)
- 1557-3265
- OpenAlex
- W2149058041
- Cited by
- 115
- References
- 8
- FWCI
- 3.15
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Dopamine Blocks Stress-Mediated Ovarian Carcinoma Growth. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-10-2441
- The paper
- Moreno-Smith, M., Lu, C., Shahzad, M. M. K., Pena, G. N. A., Allen, J. K., Stone, R. L., Mangala, L. S., Han, H. D., Kim, H. S., Farley, D., Berestein, G. L., Cole, S. W., Lutgendorf, S. K., & Sood, A. K. (2011). Dopamine Blocks Stress-Mediated Ovarian Carcinoma Growth. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-10-2441
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.